Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recruiting × Watchful Waiting × Clear all

Phase

Phase 3 8 Phase 2 5 Phase NA 4 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 12 Magnetic Resonance Spectroscopy 11 fludarabine 10 pembrolizumab 7 Specimen Handling 6 Paclitaxel 5 Immunotherapy, Adoptive 5 Fluorodeoxyglucose F18 5 Radiotherapy 4 Immune Checkpoint Inhibitors 4 Cisplatin 4 Carboplatin 4 lenvatinib 3 fluciclovine F-18 3 X-Rays 3 Surgical Procedures, Operative 3 Dasatinib 3 68Ga-FAPI 3 venetoclax 2 tislelizumab 2 temsirolimus 2 ruxolitinib 2 olaparib 2 aldesleukin 2 Tirzepatide 2 Temozolomide 2 Spironolactone 2 Radiation 2 Progesterone 2 Pafolacianine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡